Format
Sort by
Items per page

Send to

Choose Destination

Best matches for haloperidol AND neuroleptic malignant syndrome:

Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol. Yang Y et al. Shanghai Arch Psychiatry. (2014)

[Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?]. Salas de Zayas R et al. Med Intensiva. (2012)

Atypical neuroleptic malignant syndrome in H1N1 pneumonia. Crosby D et al. Ann Clin Psychiatry. (2013)

Search results

Items: 1 to 20 of 349

1.

Neuroleptic Malignant Syndrome.

Simon LV, Callahan AL.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Jan 4.

2.

Neuroleptic malignant syndrome in pregnancy: case report and literature review.

Escobar-Vidarte MF, Loaiza-Osorio S, Messa AA, Macías GE.

J Matern Fetal Neonatal Med. 2018 Feb 5:1-4. doi: 10.1080/14767058.2018.1432591. [Epub ahead of print]

PMID:
29363376
3.

Zuclopenthixol dihydrochloride for schizophrenia.

Bryan EJ, Purcell MA, Kumar A.

Cochrane Database Syst Rev. 2017 Nov 16;11:CD005474. doi: 10.1002/14651858.CD005474.pub2. Review.

PMID:
29144549
4.

Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.

Graham J, Barberio M, Wang GS.

Pediatrics. 2017 Dec;140(6). pii: e20163795. doi: 10.1542/peds.2016-3795. Epub 2017 Nov 9.

PMID:
29122973
5.

[Prolonged neuroleptic malignant syndrome after Haloperidol injection].

Wystub N, Heymel S, Fritzenwanger M, Schulze PC, Pfeifer R.

Med Klin Intensivmed Notfmed. 2018 Apr;113(3):212-216. doi: 10.1007/s00063-017-0325-6. Epub 2017 Jul 27. German.

PMID:
28752347
6.

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription.

Reilly TJ, Cross S, Taylor DM, Haslam R, Tomlin SC, Gaastra B.

SAGE Open Med Case Rep. 2017 Mar 31;5:2050313X17695999. doi: 10.1177/2050313X17695999. eCollection 2017.

7.

Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.

Ohi K, Kuwata A, Shimada T, Yasuyama T, Nitta Y, Uehara T, Kawasaki Y.

Medicine (Baltimore). 2017 Apr;96(16):e6566. doi: 10.1097/MD.0000000000006566.

8.

A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.

Jiang Y, McCombs JS, Park SH.

CNS Drugs. 2017 Apr;31(4):319-326. doi: 10.1007/s40263-017-0421-4.

PMID:
28290080
9.

Venous Thromboembolism Following Dantrolene Treatment for Neuroleptic Malignant Syndrome.

Chen PH, Lane HY, Lin CH.

Clin Psychopharmacol Neurosci. 2016 Nov 30;14(4):399-401. doi: 10.9758/cpn.2016.14.4.399.

10.

Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study.

Kameda K, Watarai K, Takahashi K, Shoko T, Koinuma M, Ikushima G.

Yakugaku Zasshi. 2016;136(6):925-9. doi: 10.1248/yakushi.15-00218. Japanese.

11.

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia.

Cheng M, Gu H, Zheng L, Wang H, Zhong Z, Wen S.

Neuropsychiatr Dis Treat. 2016 Mar 29;12:695-7. doi: 10.2147/NDT.S103687. eCollection 2016.

12.

[A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies].

Oka M, Komasawa N, Nishihara I, Fukuda M, Minami T.

Masui. 2015 Nov;64(11):1190-2. Japanese.

PMID:
26689073
13.

Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit.

Digby G, Jalini S, Taylor S.

BMJ Case Rep. 2015 Sep 21;2015. pii: bcr2014207215. doi: 10.1136/bcr-2014-207215.

14.

Neuroleptic malignant syndrome in cycloserine-induced psychosis.

Sawant NS, Kate NS, Bhatankar SS, Kulkarni PS.

Indian J Pharmacol. 2015 May-Jun;47(3):328-9. doi: 10.4103/0253-7613.157134.

15.

Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.

Lertxundi U, Ruiz AI, Aspiazu MÁ, Domingo-Echaburu S, García M, Aguirre C, García-Moncó JC.

Clin Neuropharmacol. 2015 May-Jun;38(3):69-84. doi: 10.1097/WNF.0000000000000080. Review.

PMID:
25970275
16.

Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol.

Yang Y, Guo Y, Zhang A.

Shanghai Arch Psychiatry. 2014 Dec;26(6):368-70. doi: 10.11919/j.issn.1002-0829.214099.

17.

Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.

Kimura G, Kadoyama K, Brown JB, Nakamura T, Miki I, Nisiguchi K, Sakaeda T, Okuno Y.

Int J Med Sci. 2015 Jan 5;12(2):135-40. doi: 10.7150/ijms.10453. eCollection 2015.

18.

Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood-brain barrier.

Elmorsy E, Elzalabany LM, Elsheikha HM, Smith PA.

Brain Res. 2014 Oct 2;1583:255-68. doi: 10.1016/j.brainres.2014.08.011. Epub 2014 Aug 16.

PMID:
25139421
19.

Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?

Tripathi P, Agrawal H, Goyal P, Kar SK.

Ind Psychiatry J. 2013 Jul;22(2):159-60. doi: 10.4103/0972-6748.132934.

20.

A case of recurrent neuroleptic malignant syndrome.

Ouyang Z, Chu L.

Shanghai Arch Psychiatry. 2013 Aug;25(4):256-8. doi: 10.3969/j.issn.1002-0829.2013.04.008.

Supplemental Content

Loading ...
Support Center